Agent Capital
Overview
Agent Capital is a biotech venture capital firm focused on investing in novel therapeutics that address unmet patient need. Our investment areas of focus are new products and technologies for oncology, immunology, neurology and rare disease indications. We make direct equity investments across all stages of development aligned with our two-pronged approach, which includes early-stage investments in transformative technologies (typically preclinical or Phase 1) and later-stage investments in companies approaching major inflection points (typically Phase 2/3, pre-IPO or already public).
Reach Agent Capital directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Agent Capital
What sectors does Agent Capital invest in?
Agent Capital invests in Life Sciences, Digital Health and Health Tech, and is based in Cambridge, Massachusetts, United States. Agent Capital is listed as a vc in the ConnectSafely investor database.
What stage does Agent Capital invest at?
Agent Capital backs companies at Seed, Series A and Series B, writing cheques of 500K - 15M.
Which regions does Agent Capital invest in?
Agent Capital invests across United States, Germany, Japan, France, Denmark and Sweden.
Who are the partners at Agent Capital?
Team members listed for Agent Capital include Preston Noon (General Partner, Co-Founder) and Geeta Vemuri (Founder and Managing Partner).
How do I contact Agent Capital?
Agent Capital's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
